MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with D

Dacomitinib

Dacomitinib 15mg tablets

No stability information

Stability notes for Dacomitinib 15mg tablets

There are no stability notes for this medicine.

Supplier

Vizimpro 15mg tablets (Pfizer Ltd)

Dacomitinib 30mg tablets

No stability information

Stability notes for Dacomitinib 30mg tablets

There are no stability notes for this medicine.

Supplier

Vizimpro 30mg tablets (Pfizer Ltd)

Dacomitinib 45mg tablets

No stability information

Stability notes for Dacomitinib 45mg tablets

There are no stability notes for this medicine.

Supplier

Vizimpro 45mg tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.